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Background: The purpose of this study was to evaluate the effect of the addition of 5 mg dexamethasone to 10 ml 
of 0.5% levobupivacaine on postoperative analgesic effects of ultrasound guided-interscalene brachial plexus block 
(ISBPB) in arthroscopic shoulder surgery under general anesthesia.
Methods: In 60 patients scheduled for arthroscopic shoulder surgery that underwent general anesthesia, ISBPB 
was preoperatively performed with 10 ml of 0.5% levobupivacaine under the guidance of ultrasound and a nerve 
stimulator. Patients were randomly allocated to receive the same volume of normal saline (Group I), 5 mg of 
dexamethasone (Group II), or 1 : 400,000 epinephrine (Group III) as an adjuvant to the mixture. A blind observer 
recorded total analgesic consumption, sleep quality, complication, and patient satisfaction using a verbal numerical 
rating scale (VNRS) at 0, 1, 6, 12, 24, 48 h after the operation.
Results: All patients had successful ISBPB and excellent analgesic effects less than VNRS 4 up to discharge time. 
VNRS in Group II at 12 h and 48 h was statistically much lower than in Group I and III. There were no differences in 
total analgesic consumption, sleep quality, complications, and patient satisfaction.
Conclusions: We conclude that the addition of 5 mg of dexamethasone to 10 ml of 0.5% levobupivacaine in 
ISBPB showed improvement of postoperative analgesia for arthroscopic shoulder operation without any specific 
complications. (Korean J Anesthesiol 2012; 62: 130-134)
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Introduction
Interscalene brachial plexus block (ISBPB) is one of the most 
commonly used and most clinically applicable nerve block 
techniques, particularly for shoulder joint surgery and post-
surgery pain control. In addition to the common approaches of 
the classic technique (Winnie) [1], posterior approach (Pippa) 
[2], and the modified lateral technique (Borgeat) [3], recently, 
low volume ISBPB has been developed to be easily conducted 
in real-time under ultrasonic guidance.
It has been reported that ISBPB in arthroscopic shoulder 
surgery with low dosages of bupivacaine and ropivacaine 
showed significant postoperative analgesic effects, and using 
levobupivacaine in ISBPB has been reported to have a longer 
duration of sensory block than ropivacaine [4,5]. Kim et al. [6] 
reported that the single-shot blockade effect of ultrasound-
guided ISBPB using 10 ml levobupivacaine continued for 
8 hours after the surgery. Placement of the catheter for 
continuous ISBPB can be considered for prolonged pain control 
after surgery, but it may be a challenging technique to apply to 
all patients who need arthroscopic shoulder surgery due to it 
failing to gain popularity from patients and clinicians because 
of technical proficiency [1,7,8].
For single-shot techniques, various local anesthetic (LA) 
mixtures can be used to prolong local anesthesia duration, and 
epinephrine, bicarbonate, neostigmine, opioids, and clonidine 
are frequently used for this purpose. As well as delaying 
absorption by vasoconstriction, epinephrine is the agent added 
most often to the LA, which is known to have α-2 adrenergic 
mechanism that works directly on the spinal cord to suppress 
pain, but caution is required when adding epinephrine to 
patients with risk factors such as hypertension and ischemic 
heart problems [9,10]. Addition of long-acting glucocorticoid 
steroids characterized to induce a degree of vasoconstrictor 
and anti-inflammatory effects are used to treat chronic pain 
syndrome and have been tested in some animal and human 
studies, which recently reported that adding dexamethasone 
microspheres in the LAs prolonged anesthesia duration, but 
these results also stated that dexamethasone affected the central 
nerves when added to spinal anesthesia using bupivacaine 
and the effect of systemically injected corticosteroid [11-17]. 
However, research concerning the effect on local anesthesia 
of corticosteroids added for peripheral nerve block is still very 
limited. 
Therefore, we conducted ultrasound guided-ISBPB on 
patients undergoing arthroscopic shoulder surgery using 10 ml 
0.5% levobupivacaine with added 5 mg dexamethasone and 
investigated postoperative analgesic effects.
Materials and Methods
The study was approved by the Hospitals Ethics Committee 
and was conducted on 60 American Society of Anesthesiologists 
1, 2 patients over the age of 18 who were undergoing arthro-
scopic shoulder surgery. The purposes of this study and the risks 
and complications that may come from the procedure were 
explained to subjects and their consent was obtained. Patients 
unable to cooperate, diabetics, expectant mothers, patients 
with coagulation difficulties, those sensitive to local anesthesia, 
patients with severe chronic pulmonary disease, neurological 
deficiencies at the site of operation or neuropathy, infections 
at the site of block, drug or alcohol abusers, and those with a 
medical history of chronic pain were excluded from the study. 
Patients were randomly allocated into three groups and 
ISBPB was preoperatively performed under the guidance 
of ultrasound and nerve stimulator using 10 ml of 0.5% 
levobupivacaine (Chirocaine
Ⓡ, Abbott Scandinavia AB, Solna, 
Sweden) with identical dosages of different additives. Group I 
(n = 20) was administered with 1 ml of normal saline solution, 
5 mg of dexamethasone (Dexamethasone disodium phosphate 
injection
Ⓡ, Yuhan Pharm, Seoul, Korea) was administered to 
Group II (n = 20), and 1 : 400,000 epinephrine was administered 
to Group III (n = 20). 
Noninvasive monitoring of blood pressure, pulse oxymetry 
and electrocardiograms were attached to all patients immedia-
tely after arrival into the operating room, and their initial vital 
signs were measured. ISBPB was conducted after IV injection 
of midazolam 1-3 mg and fentanyl 25-50 μg. The patient was 
laid in a supine position with the head turned away from the 
side to be blocked. Betadin was applied to the skin, and the 
round to oval-shaped honeycomb appearance of hypoechoic 
nerve roots in short-axis view located between the anterior 
scalene muscle (ASM) and middle scalene muscle (MSM) were 
identified using a 5-12 MHz linear probe of ultrasound (SonoSite 
M-TurboTM, SonoSite, Bothell, USA). The point where the 
C5/6/7 roots were most visible was selected. The linear probe 
was draped with disinfected wrap and gel, and a 22 G 50 mm 
length needle (Stimuplex
Ⓡ, B. Braun Melsungen, Melsungen, 
Germany) con  nected to a nerve stimulator (Stimulplex DIG
Ⓡ, 
B. Braun, Melsun  gen, Germany) was used to approach via the 
in-plane method. The needle tip was positioned between the 
C5/6 roots or superior trunk within the sheath, and LAs for each 
group were slowly administered after any twitch confirmation 
from the deltoid, pectoralis major, triceps, or biceps through 
1 Hz and less than 0.5 mA of electrical stimulation, and when 
blood was not absorbed through suction (to rule out injection 
into the bloodstream). Medication diffusion was observed with 
ultrasound, and needle position was adjusted so all nerve roots 
within the sheath could be surrounded. All ISBPB procedures 132 www.ekja.org
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were conducted by one anesthesiologist, and all surgeries were 
performed by one surgeon. 
After the procedure, general anesthesia induction was done 
immediately. A bispectral index was mounted on all three 
groups and after IV injecting glycopyrrolate 0.2 mg, pentothal 
sodium (4 mg/kg), fentanyl (1-2 μg/kg) and rocuronium 
(0.6 mg/kg) were used to intubate. General anesthesia was 
maintained using 50% oxygen-nitrous oxide mixture and 
sevoflurane(0.5-2.0 vol%) to control BIS value to 40-60 and 
systolic blood pressure to 90-100 mmHg. Pyridostigmine and 
glycopyrrolate were used for reversal of the residual muscle 
relaxation.
A doctor blinded to the study groups visited the patients 
and used the verbal numerical rating scale (VNRS: 0 = no pain, 
10 = most severe pain imaginable) to evaluate and record pain 
starting with immediately after recovery room arrival as 0 and 
1, 6, 12, 24, and 48 h later. When VNRS was more than 4 and the 
patient requested analgesic, ketorolac was IV injected or opioid 
IM injected and recorded, and patients were evaluated whether 
they exhibited complications such as neurological disabilities, 
nausea, vomiting, or respiratory difficulties. 
SPSS (version 17.0, Chicago, IL, USA) was used for statistical 
analysis and continuous variables were noted as mean ± 
standard deviation, VNRS as mean ± standard error and 
analyzed using ANOVA. Categorical variables were noted in 
number of patients (%) and analyzed using chi-squared and 
Fisher’s exact test. A P value of < 0.05 was considered statisti-
cally significant. 
Results
There were no significant differences in age, height, weight, 
sex, ASA PS, time taken for surgery and anesthesia, and type 
of surgery among the three groups (Table 1). Patients from all 
three groups showed excellent analgesic effects with VNRS 
lower than 1 point up to 6 h after surgery. 
VNRS measured at 12, 24 and 48 h after surgery showed that 
of Group II scored 0.3, 2.4, 1.1 points, which was notably lower 
compared to Group I (2.6, 3.7, 2.9 points) and Group III (3, 3.5, 
2.6 points) (Fig. 1). However, all three groups exhibited excellent 
analgesic effect with lower than 4 points in VNRS measured 
up to 48 hours after surgery, and the amount of additional 
analgesic used was not significantly different. All nerve blocks 
were recovered within 24 hours, and all patients were satisfied 
with no complaints of complications or side effects. 
Discussion
This study conducted ultrasound-guided single-shot ISBPB 
on patients undergoing arthroscopic shoulder surgery using 
0.5% levobupuvacaine 10 ml. This procedure showed excellent 
pain control of less than 1 point VNRS up to 6 hours post-
surgery. When 5 mg dexamethasone was added to the ISBPB 
Fig. 1. Verbal numerical rating scale (VNRS) according to the time 
interval after arthroscopic shoulder surgery. Values are expressed 
as mean ± SD. *P < 0.05 compared with Group I. Group I: 1 ml 
normal saline as an adjuvant to 10 ml of 0.5% levobupivacaine 
for interscalene brachial plexus blockade, Group II: 1 ml of 5 mg 
dexamethasone as an adjuvant to 10 ml of 0.5% levobupivacaine 
for interscalene brachial plexus blockade, Group III: 1 : 400,000 
epinephrine as an adjuvant to 10 ml of 0.5% levobupivacaine for 
interscalene brachial plexus blockade.
Table 1. Demographic and Clinical Data for Ultrasound Guided 
Interscalene Brachial Plexus Blockade in Arthroscopic Shoulder 
Surgery
Group I
(n = 20)
Group II
(n = 20)
Group III
(n = 20)
Age (yr) 
Height (cm) 
Weight (kg) 
Sex (M/F) 
ASA (I/II) 
Duration of 
  operation (min) 
Duration of 
  anesthesia (min) 
Operative type 
    Rotator cuff repair 
    ASD 
    SLAP repair 
    Bankart repair 
    Capsular shifting 
50.8 ±14.6
164.9 ± 8.9
68.9 ±11.2
15/5
  9/11
84.3 ±23.7
143.8 ± 29.4
13
  1
  4
  1
  1
47.0 ± 15.5
162.7 ± 9.2
68.3 ± 11.2
12/8
  6/14
76.5 ± 21.1
141.4 ± 26.7
14
  2
  3
  1
  0
44.2 ± 16.7
167.9 ± 8.7
71.8 ± 13.3
13/7
10/10
71.8 ± 13.3
150.5 ± 40.6
10
  1
  5
  2
  2
Values are expressed as mean ± SD or numbers. Group I: 1 ml 
normal saline as an adjuvant to 10 ml of 0.5% levobupivacaine 
for interscalene brachial plexus blockade, Group II: 1 ml of 5 mg 
dexamethasone as an adjuvant to 10 ml of 0.5% levobupivacaine 
for interscalene brachial plexus blockade, Group III: 1 : 400,000 
epinephrine as an adjuvant to 10 ml of 0.5% levobupivacaine 
for interscalene brachial plexus blockade. ASD: arthroscopic 
subacromialdecompression, SLAP: superior labrum anterior 
posterior. There were no significant differences among the groups.133 www.ekja.org
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procedure, the VNRS was notably lower than adding normal 
saline solution or 1 : 400,000 epinephrine up to 48 hours post-
surgery, and it showed excellent extension of the pain control 
period without complications or side effects. 
Arthroscopic shoulder surgery is known to cause severe 
post  operative pain similar to gastrectomy or thoracotomy 
[7,18]. ISBPB is conducted with local or general anesthetic for 
arthroscopic shoulder surgery and is not only an anesthetic 
method that allows easier blood pressure control during 
surgery, but also allows easier postoperative pain control. Thus, 
this method is used frequently because it reduces the need for 
opioids or analgesics, which in turn reduces nausea, vomiting 
and hypoxia [6-8,19,20]. Singelyn et al. [20] reported that ISBPB 
exhibited more effective analgesic effect during the first 24 
hours than suprascapular nerve block or subacromial/intra-
articular injection. Single-shot ISBPB provides excellent pain 
control effect for arthroscopic shoulder surgery compared to 
other methods, but the limitation is that the duration of pain 
control period is short. To counteract this, various medications 
are added and effective pain control is achieved [9-11,21]. Kim 
et al. [6] reported excellent pain control effects up to 8 hours 
post-surgery using 0.25% and 0.5% levobupivacaine 10 ml in 
single-shot ISBPB under ultrasound guidance. In our study, 
ISBPB was conducted within the sheath of the interscalene 
brachial plexus using 10 ml of levobupivacaine, and the in-
plane approach method was used to insert the needle. Direct 
damage to nerves and surrounding tissue from needle insertion 
was prevented by checking ultrasound images during insertion. 
Appropriate spread of LAs within the interscalene brachial 
plexus sheath was ascertained during administration, and 
the location of the needle tip was adjusted when needed. This 
allowed LAs injection into the appropriate areas for sufficient 
perfusion through the nerve trunk and roots so successful 
nerve block was properly achieved in all patients without 
complications and pain control effect of less than 1 VNRS up to 
6 hours post-surgery was observed. These results are similar to 
those of previous studies. 
Using 1 : 400,000 epinephrine as an adjuvant to levobupi-
vacaine 10 ml, Group III was not statistically different to Group I, 
which used normal saline as an adjuvant, in VNRS comparison, 
over time. Existing research reporting positive results [22,23] 
had used relatively large dosages of bupivacaine or ropivacaine 
injected into the brachial plexus sheath between the ASM and 
MSM, and the small amount of epinephrine used to constrict 
the surrounding blood vessels to delay local anesthesia 
absorption, which led to prolonged pain control period. In our 
study, however, epinephrine did not result in a prolonged pain 
control period. The first reason may be the pharmacological 
difference caused by levobuvacaine, which is a S(-) isomer 
of bupivacaine and is known for safer applications and lower 
possibility of adverse cardiovascular effects or neurotoxicity. 
The second reason may be that epinephrine could not function 
as a vasoconstrictor because local anesthesia was used in 
such small amounts to the cervical nerve roots or nerve trunks 
located within the space of the sheath, and injection was limited 
within the sheath.
In our study, when ISBPB was conducted with 5 mg of 
dexa  methasone as an adjuvant to levobupivacaine, a notable 
pain control extension effect could be observed up to 48 
hours post-surgery. Existing studies of the pain control effect 
of dexamethasone in local anesthesia reported that the pain 
control period was significantly prolonged in IV regional 
anesthesia or axillary BPB using lidocaine, and supraclavicular 
BPB conducted with epinephrine as an adjuvant to bupivacaine 
[15,16,24]. However, these results could not completely exclude 
the systemic effect of corticosteroids. Moreover, epinephrine 
and/or clonidine were used together, so the sole effect mecha-
nism of dexamethasone on LAs could not be fully explained. 
The analgesic mechanism of corticosteroids is not yet fully 
understood, and there is little known about the functional or 
structural influence of corticosteroids on normal peripheral 
nerve fibers [25,26]. However, it has been reported that the 
steroids induce a degree of vasoconstriction, which results in 
reducing LA absorption, and they attach to the intracellular 
receptor to modulate nuclear transcription [15]. Stan et al. [19] 
argued that the steroid suppresses the synthesis and secretion 
of various inflammatory mediators, which prolongs the period 
of analgesia up to 48 hours, and Attardi et al. [27] showed that 
dexamethasone act on glucocorticoid receptors, which increase 
the activity of inhibitory potassium channels on nociceptive 
C-fibers. This result concurs with ours, but more research on 
the influence of steroids on peripheral nerve fibers and its 
mechanisms is necessary. 
The danger of using dexamethasone within the nerve 
sheath is still controversial. In animal experiments, repeated 
intrathecal injections of small dosages of bethamethasone 
and triamcinolone did not cause spinal toxicity, but repeated 
intrathecal injection of high dosages of betamethasone resulted 
in histological changes in the spinal cord [13,14]. In contrast, 
neurological abnormalities were not observed when repeated 
spinal injection of 8 mg dexamethasone was applied to treat 
post-traumatic visual disturbance. Therefore, neural damage 
appears to be highly related to direct trauma by the needle. In 
addition, it is reported that single use of small amounts (less 
than 8 mg) of dexamethasone, or use within 24 hours, is safe 
for adults [15,28,29]. In our study, a smaller dose of 5 mg of 
dexamethasone was injected between the C5/6 roots within 
the sheath, while checking the nerves and spread of local 
anesthesia through ultrasound images. This may be why the 
procedure was highly successful, since all nerve blocks were 134 www.ekja.org
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completely recovered within 24 hours without neural damage, 
and the excellent analgesic effect lasted up to 48 h post-surgery. 
In conclusion, using low dosage 0.5% levobupivacaine 10 ml 
in ultrasound-guided single shot ISBPB for patients undergoing 
arthroscopic shoulder surgery showed an excellent pain control 
effect of less than 1 point of VNRS up to 6 hours post-surgery. 
Furthermore, when 5 mg dexamethasone was used as an 
adjuvant in the ISBPB, it showed excellent pain control period 
extension of low VNRS up to 48 hours post-surgery without 
specific complications when compared to adding the same 
volume of adjuvant normal saline or 1 : 400,000 epinephrine.
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